Welcome to our dedicated page for Aimei Health Technology Co SEC filings (Ticker: AFJK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aimei Health Technology Co., Ltd (NASDAQ: AFJK) files detailed reports with the U.S. Securities and Exchange Commission as a blank check company formed to complete a business combination. As a Cayman Islands exempted SPAC in the Financial Services sector, its SEC filings explain its structure, trust account arrangements, shareholder rights, and the terms of its proposed transaction with United Hydrogen Group Inc. and United Hydrogen Global Inc. (Pubco).
On this page, you can review Aimei Health’s key filings, including Form 8-K current reports describing material events such as the execution of the business combination agreement, monthly extensions of the termination date, and the issuance of unsecured promissory notes to its sponsor and United Hydrogen to fund extension payments. These 8-Ks also disclose voting results from extraordinary general meetings where shareholders consider the business combination proposal, merger proposal, share issuance proposal, and adjournment proposal, along with information on public share redemptions.
Aimei Health’s DEF 14A definitive proxy statements provide extensive detail on the proposed business combination and related matters. They describe the structure of the mergers with United Hydrogen and Pubco, the exchange mechanics for Aimei Health units, ordinary shares, and rights, the aggregate merger consideration, and the expected ownership and voting power distribution in Pubco. Proxy materials also outline proposed amendments to the company’s articles and trust agreement to extend the deadline to complete a business combination and adjust monthly extension fees.
Through this filings page, users can access Aimei Health’s registration and proxy materials, current reports, and related exhibits. AI-powered summaries can help interpret complex sections, such as share exchange ratios, dual-class voting structures at Pubco, redemption mechanics for public shareholders, and the financial obligations created by promissory notes. This allows investors to quickly understand how each filing affects AFJK’s path toward completing its business combination and the implications for holders of its units, ordinary shares, and rights.
Aimei Health Technology Co., Ltd extended the deadline to complete its initial business combination by one month, moving the termination date from October 6, 2025 to November 6, 2025. To fund this extension, an aggregate $150,000 was deposited into the company’s trust account for public shareholders.
The company issued a $150,000 unsecured promissory note dated October 8, 2025 to its sponsor, Aimei Health Ltd, and United Hydrogen Group Inc., with each contributing $75,000. The note bears no interest and becomes payable when Aimei completes its business combination with United Hydrogen. The payees may choose to convert the note into private units at $10.00 per unit, with each unit consisting of one ordinary share and a right to receive one-fifth of one ordinary share, immediately prior to closing the business combination.